Robotics automation theme cools as investors get selective, with earnings-price disconnects and healthcare robotics holding up as quality counterweight.
Why ISRG Stock advanced +1.03% Today — RQD Quant Desk Flash
Intuitive Surgical Inc. (ISRG) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why ISRG Stock advanced +1.03% Today — RQD Quant Desk Flash
Intuitive Surgical Inc. (ISRG) advanced +1.03% to $448.76 as options desks priced 57% call premium vs. 43% put protection around the $440 max-pain magnet. Solid 66% profit margin (15% return on capital), mixed timing at 55x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 44% of its 52-week range ($328.57 – $603.88) with RSI-14 at 54.1 (NEUTRAL RANGE).
- ▸Whale Options Positioning: $15.9M in bullish call flow vs. $12.1M in put flow (Put/Call 0.76x, implied earnings swing ±6.8%).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 66% gross margin and $2.6B annual free cash flow.
Intuitive Surgical's surging robotic surgery demand and stronger earnings momentum make it a better buy than Boston Scientific despite its valuation premium.
Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 20 years by 11.31% on an annualized basis producing an average annual return of 20.16%. Currently, Intuitive Surgical has a market
DVA's Q3 earnings surge 52.2% as revenues rise 4.6%, fueled by strong kidney care and international growth despite rising costs and margin pressure.
ResMed's first-quarter fiscal 2027 earnings and revenues top estimates as sustained sleep device demand, productivity gains and gross margin expansion drive growth.
Intuitive Surgical's third-quarter sales surged 22%, outpacing procedure growth. Can system placements, new technologies and recurring revenues offset pricing pressures?
BAX beats Q3 earnings and revenue estimates, driven by broad-based segment growth, and raises its 2026 outlook despite continued margin pressure.
For questions about this article or underlying research, email help@trefis.com.
For questions about this article or underlying research, email help@trefis.com.
For questions about this article or underlying research, email help@trefis.com.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live ISRG Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
ISRG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +20.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ISRG today. View full Setup Ledger →
ISRG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ISRG stock moving today?
Why ISRG Stock advanced +1.03% Today — RQD Quant Desk Flash. Solid 66% profit margin (15% return on capital), mixed timing at 55x P/E—hold if owned, no rush to chase.